VITA 34 AG
4.00
-0.06 (-1.48%)
At close: Jan 15, 2025, 12:25 PM
undefined%
Bid n/a
Market Cap 69.73M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 0.17
PE Ratio (ttm) 23.53
Forward PE n/a
Analyst n/a
Ask n/a
Volume 38
Avg. Volume (20D) 981
Open 4.08
Previous Close 4.06
Day's Range 4.00 - 4.08
52-Week Range 3.69 - 5.90
Beta undefined

About V3V.DE

VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; ...

Sector Healthcare
IPO Date Mar 27, 2007
Employees 745
Stock Exchange XETRA
Ticker Symbol V3V.DE
No News article available yet